ClinicalTrials.gg
Drug

Levetiracetam clinical trials

Also written AGB101.

studies test it
204
open now
23
in phase 3
57
first study started
1998

How each study uses Levetiracetam is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Levetiracetam studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Nov 1999 · KEPPRA · NDA 021035 (FDA, Drugs@FDA)
European Union
29 Sept 2000 · Keppra · EMEA/H/C/000277 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Levetiracetam
150
Keppra
82
Levetiracetam (Keppra)
10
Intravenous levetiracetam
4
E-Keppra
4

Development codes

AGB101
3

Studies by the year they started

203 studies that test it; most in 2007 (25)

Studies that test Levetiracetam, by start year
YearStudies
19981
19991
20002
20016
20025
200311
200412
200519
200613
200725
20086
20097
20104
20119
20124
201310
20144
20156
20161
20175
20186
20195
20205
20215
20221
20237
20246
202512
20265

By phase

A phase 1/2 study counts in both.

Phase 1
24
Phase 2
62
Phase 3
57
Phase 4
44
No phase
28

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 73 · Other 131

UCB Pharma (40) · UCB Japan Co. Ltd. (10) · Johns Hopkins University (4) · Teva Pharmaceuticals USA (4) · UCB Pharma SA (4) · Yale University (4) · Roxane Laboratories (4) · Duke University (4)

Often tested with

Tested in the same studies.

Valproic Acid (8) · Lamotrigine (8) · Phenytoin (7) · Lacosamide (7) · Phenobarbital (6) · Carbamazepine (5) · Fosphenytoin (4) · Zonisamide (4)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 8, 2 in phase 3

Studies that test Levetiracetam, phase 3 first.

Studies

Open first, then newest update. How each study uses Levetiracetam is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 204

See all 204 studies that test Levetiracetam →

Given beside what is tested · 13 — Levetiracetam is usual care or a partner of the new treatment
As the comparator · 6 — what is tested is compared with Levetiracetam

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Levetiracetam · ClinicalTrials.gg INT006688

  • MeSH (NLM) D000077287LevetiracetamConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 44YRR34555LEVETIRACETAMConfirmed FDA, NLM
  • RxNorm 114477One source FDA
  • NCI Thesaurus C47581LevetiracetamOne source FDA

Also registered as etiracetam (UNII 230447L0GL) and etiracetam, (r)- (UNII 73HC18Y1LW).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.